Skip to Content
Merck
CN
  • Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.

Rifampicin-induced acute kidney injury during the initial treatment for pulmonary tuberculosis: a case report and literature review.

Internal medicine (Tokyo, Japan) (2013-11-06)
Sahoko Chiba, Kimitake Tsuchiya, Hiroyuki Sakashita, Eisaku Ito, Naohiko Inase
ABSTRACT

A 47-year-old man diagnosed with pulmonary tuberculosis was referred to our hospital. Rifampicin, isoniazid, pyrazinamide and ethambutol were administered, and the patient's symptoms promptly improved. On the 19th hospital day, he developed acute kidney injury with a fever and chills. Renal biopsy specimens indicated tubulointerstitial nephritis. Suspecting rifampicin-induced acute kidney injury, we discontinued the rifampicin and administered levofloxacin in its place. The patient's serum creatinine level subsequently gradually improved. We herein report this case and review eight cases reported in Japan. We found that the rifampicin toxicity appeared at both the initial administration and readministration. All eight patients presented with proteinuria.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Rifampicin, ≥95% (HPLC), powder or crystals